PSMA PET scanning is a relatively new diagnostic technology that greatly assists in localising the extent of prostate cancer. It can do this not only in the area of the prostate but also in the lymph glands and bones. As a result, therapy can be targeted more appropriately.

PSMA PET/CT scanning is much more accurate than other scanning methods described to date. This includes the more established Choline PET-CT scan. However, whilst PSMA PET/CT scanning is a very sensitive imaging technology (especially when the PSA is above 0.2) in less than 2% of patients a positive scan proves to be a false positive.

Overall it has been a major advance in the detection of secondary cancer.

About Phillip

Phillip is the Chairman of the Department of Urology, St Vincent's Private Hospital and Clinic since 2003, and a Director of the St Vincent's Prostate Cancer Centre.

The Australian Prostate Cancer Research Centre in New South Wales recently appointed him as clinical director. He is also a member of the National Prostate Cancer Research Centre

Philip is currently the highest volume robotic surgeon in Australasia

He is perhaps best known for his work developing nerve sparing techniques to help patients maximise potency